Skip to main content Help with accessibility Skip to main navigation

Recommendations

Coronavirus guidance

Guidance to support primary care prescribers and pharmacists is available from the MLCSU Coronavirus guidance resource page. Links are provided to national resources and regional documents produced by MLCSU, RDTC, and SPS for use by Pan Mersey APC, LSCMMG, and GMMMG.

The list of resources will be updated as new material becomes available so please check back regularly for updates.

The Pan Mersey APC supports the use of COVID-specific guidance issued by NICE, and NHS England and NHS Improvement. During the COVID pandemic this will supersede any APC advice. In the absence of any COVID-specific advice then the usual Pan Mersey guidance and RAG rating will still apply unless otherwise indicated.

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and Criteria for Categorisation of Medicines

Documents

Date Added: 11 - Apr - 2018

The Pan Mersey Area Prescribing Committee recommends the prescribing of abatacept infusion and subcutaneous injection (Orencia ®) for rheumatoid arthritis and infusion for polyarticular juvenile idiopathic arthritis as described below.

Static

Body System:
Date Added: 30 - Nov - 2018

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of oral acetylcysteine in idiopathic pulmonary fibrosis.

Body System:
Date Added: 11 - Apr - 2018

The Pan Mersey Area Prescribing Committee recommends the prescribing of adalimumab injection (Humira®) for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and in patients fitting other criteria commissioned by Pan Mersey CCGs, as described.

Static

Body System:
Date Added: 07 - Jul - 2016

The Pan Mersey Area Prescribing Committee recommends the prescribing of ALIROCUMAB (Praluent®▼) by specialists only, for treating primary hypercholesterolaemia and mixed dyslipidaemia in accordance with NICE TA393.

Body System:
Date Added: 26 - Apr - 2019

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of ALIROCUMAB solution for injection (Praluent®▼) for reduction of cardiovascular risk in adults with established atherosclerotic cardiovascular disease.

Body System:
Date Added: 30 - Jan - 2020

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of ALISKIREN tablets (Rasilez®).

Body System:
Date Added: 07 - Jun - 2017

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of antioxidant supplements based on the AREDS or AREDS2 formulae for patients with age related macular degeneration.

Static

Body System:
Date Added: 25 - Jan - 2017

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of ASCORBIC ACID for any indication, other than scurvy.

Date Added: 24 - Feb - 2020

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of AVATROMBOPAG tablets (Doptelet®▼) for treating severe thrombocytopenia in adults with chronic liver disease having planned invasive procedures.

Date Added: 23 - Oct - 2019

The Pan Mersey Area Prescribing Committee recommends the prescribing of azithromycin following specialist initiation for certain chronic airway conditions in children.

Body System:
Date Added: 25 - Nov - 2015

The Pan Mersey Area Prescribing Committee recommends the prescribing of azithromycin tablets in selected high risk patients, when recommended by a respiratory specialist, for the prevention of exacerbations in COPD and bronchiectasis.

Body System: